Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
Wendy H. Updike, Olivia Pane, Rachel Franks, Faizah Saber, Farah Abdeen, Derek D. Balazy, Nicholas W. Carris
Topics & Concepts
MedicineWeight lossLiraglutideSemaglutideType 2 diabetesExenatideInternal medicineDiabetes mellitusDulaglutideOverweightEndocrinologyGlucagon-like peptide 1 receptorBody mass indexObesityAgonistReceptorDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer